Hysterectomy and Bilateral Salpingectomy Guidelines

Introduction to the Procedure

The National Comprehensive Cancer Network recommends hysterectomy with bilateral salpingo-oophorectomy as a standard procedure for gynecologic conditions like endometrial and ovarian cancer 1, 2
Standard surgery involves total hysterectomy with bilateral salpingo-oophorectomy, which includes removal of the uterus, fallopian tubes, and ovaries 2, 3

For benign conditions, the procedure may involve a total hysterectomy with bilateral salpingectomy, preserving the ovaries 4
The surgical approach may be abdominal, laparoscopic, or vaginal, each with specific indications and considerations 5, 3

Key pelvic anatomy to be familiar with during the procedure includes the uterine blood supply, ureter location and course, fallopian tubes and their blood supply, and ovarian ligaments and blood supply if ovaries are being preserved 1, 2, 6, 5

Hysterectomy with bilateral salpingectomy may be performed for gynecologic malignancies, such as endometrial, ovarian, or cervical cancer 1, 2
The procedure may also be indicated for benign conditions like fibroids, endometriosis, or abnormal uterine bleeding 7

The abdominal approach is used for large uteri, suspected malignancy, or when extensive adhesions are expected 2
The laparoscopic approach is associated with fewer moderate-to-severe postoperative adverse events and shorter hospital stays compared to open procedures 5, 3

On entering the abdomen, aspiration of ascites or peritoneal lavage may be performed for cytologic examination in cases of suspected malignancy 2, 6
A maximal effort should be made to remove all gross disease in cancer cases 1
In benign cases, care should be taken to identify and preserve the ureters and major blood vessels 2

In premenopausal women, ovarian preservation may be considered to prevent premature menopause 5, 8
Hormone replacement therapy should be considered for women experiencing premature menopause due to hysterectomy with oophorectomy 8

Intra‑abdominal access via a laparotomy requires general anesthesia and imposes moderate physiologic stress on the patient. 9
The operation involves manipulation of multiple organ systems (removal of the uterus, both ovaries, and fallopian tubes). 10
Comprehensive staging (peritoneal washings, random peritoneal biopsies, infracolic omentectomy, and pelvic/para‑aortic lymph‑node sampling) extends operative time beyond that of a simple hysterectomy. 9

When performed by appropriately trained gynecologic oncologists, the procedure demonstrates a well‑established safety profile in average‑risk patients. 11
Minimally invasive (robotic) approaches, when feasible, reduce major complication rates to approximately 6 % compared with about 20 % for open laparotomy. 10

The procedure does not meet criteria for high‑risk surgery because it does not require extensive cytoreductive resections of bowel, diaphragm, or other organs. 9
Patients without significant comorbidities are not elevated to a higher risk category. 12
Standard staging components are well tolerated in appropriately selected patients. 11

In women younger than 45 years with less than 50 % myometrial invasion and no family history of ovarian cancer, ovarian preservation should be considered. 13

Staging‑indicated cases should be performed by a gynecologic oncologist who has specific training and experience in ovarian‑cancer management. 9